Pediatric burn hypermetabolism and nutrition
Summary
- What it covers: The catecholamine-driven hypermetabolic response in burned children and the nutritional and pharmacologic strategies that counter energy expenditure and muscle catabolism [1][5].
- Clinical bounds: Children with severe burns, conventionally above 10% TBSA, in whom catabolism and raised energy expenditure persist up to two years [23][3].
- Core principles: Feed early and enterally to measured targets, control hyperglycemia, and modulate the response with propranolol and oxandrolone rather than calories alone [9][23][35].
- Pediatric: Growing children carry small reserves; unchecked catabolism causes growth arrest, so anabolic and beta-blocking agents are used long after the wound heals [35][39].
Key Points
- Recognize: Severe burns trigger a hypermetabolic, catabolic state with elevated resting energy expenditure that persists up to two years and impairs growth and rehabilitation [2]. → Pathophysiology
- Recognize: Predictive equations are unreliable in burned children, so measured resting energy expenditure by indirect calorimetry is the recommended target for feeding [18][16]. → Assessment
- Immediate action: Start enteral feeding early; early enteral nutrition lowers underfeeding, shortens ICU stay, and reduces mortality versus parenteral or delayed feeding [23][22]. → Management
- Immediate action: Overfeeding does not build lean mass; calories beyond about 1.2 times resting energy expenditure add only fat, so match intake to need [9]. → Management
- Watch for: Persistent hyperglycemia raises mortality and impairs graft take; control glucose while avoiding the hypoglycemia that intensive insulin protocols cause [30][49]. → Complications
- Unresolved: Mortality benefit of beta-blockade and of high-protein diets is not established, and propranolol dosing and duration vary widely between centers [50][52]. → Controversies and Evidence Gaps
- Special populations: Infants under one year with large burns have poorer survival [43]; and it is children over four, not the youngest, who lose weight and lean mass [42]. → Special Considerations
Overview¶
A severe burn in a child sets off one of the most extreme stress responses in medicine. Catecholamine release drives a hypermetabolic state marked by increased energy expenditure, insulin resistance, immunodeficiency, and whole-body catabolism [1]. The clinical consequence is muscle that wastes faster than it can be rebuilt, a child who cannot defend lean mass on calories alone, and a metabolic disturbance that outlasts the wound by months to years [2]. Nutritional support and metabolic modulation are not adjuncts to burn care in this population; adequate nutrition in the severely burned child often determines morbidity and mortality and demands high priority in management [53].
The burned child is not a small adult. Children carry smaller energy reserves, have higher baseline protein and energy requirements for growth, and suffer growth retardation when the catabolic response goes unchecked [44]. This page covers the pathophysiology of the hypermetabolic response, how to assess energy needs, the nutritional strategy that anchors management, the pharmacologic agents that modulate the response, the complications that follow both the injury and its treatment, and the questions that remain unsettled.
Pathophysiology¶
The hypermetabolic response is catecholamine-mediated. Severe burns trigger a chronic state of sympathetic nervous system activation associated with hypermetabolic and cardiac stress and muscle wasting [45]. Resting energy expenditure rises sharply: in burned children studied serially, it was elevated 40% above predicted during the acute phase and 50% during the flow phase, returning toward normal only during convalescence [8]. Much of this is thermoregulatory. Burned children lose heat at a rate 27 watts per square meter above predicted, mostly by evaporation, which increases 300%, and heat production rises to match heat loss [10]. The increased heat production is a response to the increased rate of heat loss, not the reverse, which is why reducing evaporative loss reduces energy demand [10].
The catabolic limb is driven by accelerated protein breakdown. Plasma fluxes of essential amino acids increase across the acute and flow phases, indicating that protein breakdown outpaces synthesis [8]. Catecholamines stimulate the beta-2 adrenergic receptor to drive lipolysis [6], and the resulting fatty-acid load contributes to fatty liver, which often doubles liver size in severely burned patients [7]. Anabolic hormones move in the wrong direction: endogenous anabolic agents fall three- to fivefold for up to 40 days post-trauma despite adequate nutrition, and higher anabolic hormone levels track with improved survival [11].
What distinguishes the pediatric response is its duration. Recovery from a massive burn is characterized by catabolic and hypermetabolic responses that persist up to two years and impair rehabilitation and reintegration [2]. The derangement is not confined to the acute admission. At six and nine months after injury, glucose metabolism remains abnormal with elevated glucose and insulin responses [12], muscle protein synthesis stays elevated for at least a year [14], and at six months leg muscle is anabolically unresponsive to amino acid infusion while whole-body protein breakdown remains higher than in controls [13]. This persistent hypermetabolic state delays anabolism and growth in burned children [15], which is why metabolic management extends well beyond wound closure.
Assessment¶
Energy assessment in the burned child is the single most error-prone step in nutritional management, because the predictive formulas fail. Thermally injured patients are variably hypermetabolic, and energy expenditure cannot be precisely predicted [16]. In burned children, predicted resting energy expenditure from standard equations is significantly lower than measured values, all common equations underpredict, and agreement between predicted and measured values is poor [18]. The classic formulas overestimate in the opposite direction when applied to total caloric need: nutritional formulas in popular use overestimate caloric requirements in severe burns, and measured resting energy expenditures in burned children ran 30 to 40% below the actual caloric intake required to maintain weight [17].
The practical consequence is that measurement beats prediction. Indirect calorimetry is the recommended method for determining resting energy expenditure in severely burned children [18]. Where calorimetry is unavailable, surface-area-based formulas calibrated to modern burn care perform better than older weight-based equations; one pediatric formula derived against measured intake provides 1300 kcal per square meter burned, fully 900 kcal per square meter less than its predecessor [19], a reminder that legacy formulas systematically overfed. Caloric requirement per square meter of burn also differs significantly by age between the three-and-under group and older children [57], so a single formula cannot serve the whole pediatric range.
Management¶
Feed early and feed enterally¶
The foundation of metabolic support is early enteral nutrition. Early enteral feeding decreases intestinal permeability, preserves the intestinal mucosal barrier, and reduces enterogenic infection by limiting the endotoxin and TNF-alpha rise seen with delayed feeding [21]. In a comparison of early enteral versus total parenteral nutrition, mortality was significantly lower in the enteral group (14.65% versus 36.58%), with faster immune recovery and lower cortisol [22]. In pediatric burns specifically, an early enteral nutrition group had lower rates of underfeeding in the first week and shorter ICU stay than later-fed children, leading the authors to recommend feeding within four hours of admission for burns at or above 10% TBSA [23]. Early feeding also blunts the response directly: resting energy expenditure fell by an average of 27% across the first two weeks in an early-feeding group compared with delayed feeding, with lower glucagon, cortisol, and catecholamines [24].
Perioperative fasting is a recurring threat to this strategy, because burned children return to the operating room repeatedly. A preoperative fast in critically ill burn patients caused loss of more than half the prescribed calories on the day of surgery, though a structured catch-up protocol compensated for the deficit about two-thirds of the time [26]. Continuous intraoperative duodenal feeding is one answer; in pediatric burn patients it appears safe with no reported aspiration events [25]. Cumulative deficits matter: in mechanically ventilated burn patients, energy and protein deficits were associated with increased mortality, and the larger the deficit the stronger the association with death [27].
Match calories to measured need, not to formulas¶
More is not better. Increased caloric balance did not attenuate erosion of lean body mass; instead fat mass increased with caloric supply, and caloric delivery beyond 1.2 times resting energy expenditure produced fat without any gain in lean mass [9]. This is the central argument for measured targets over generous formula-driven feeding. Macronutrient composition also matters in children: enteral nutrition supplied predominantly as carbohydrate rather than fat improved net skeletal muscle protein balance by decreasing protein breakdown, a protein-sparing effect [20]. Low-fat nutrition support decreased infectious morbidity, with fewer cases of pneumonia, and shortened length of stay [28]. The conventional reflex toward very-high-protein feeding is on weaker ground, discussed under controversies.
Reduce the metabolic load directly¶
Two non-nutritional measures lower energy demand. Reducing evaporative heat loss with occlusive dressings cuts the rate of heat loss and substantially reduces energy requirements even in very large burns [10]. Warming the environment toward thermoneutrality works on the same principle. These measures reduce the calorie target that nutrition must then meet.
Modulate the response pharmacologically¶
When feeding and environmental control are not enough, two agents have the strongest pediatric randomized evidence.
Propranolol. Beta-blockade is the best-studied modulator of the hypermetabolic response in children. In the landmark pediatric randomized trial, propranolol during hospitalization decreased heart rate and resting energy expenditure, increased net muscle-protein balance by 82% over baseline while controls lost ground, and preserved fat-free mass that fell 9% in untreated children [5]. The conclusion was direct: in children with burns, propranolol attenuates hypermetabolism and reverses muscle-protein catabolism [5]. The mechanism is dual. Propranolol cuts cardiac work, reducing heart rate, left ventricular work, and rate-pressure product by 20%, 22%, and 36% respectively [4], and it blunts the beta-2-mediated lipolysis that fuels fatty liver, reducing the hepatomegaly seen in 80% of untreated burned children to no change or shrinkage in 86% of treated children [40]. Propranolol significantly decreased resting energy expenditure during acute hospitalization [54], and long-term treatment reduced predicted heart rate and energy expenditure, decreased central fat, prevented bone loss, and improved lean-mass accretion [3]. Dosing is titrated to effect, commonly to reduce heart rate by 20% of baseline at roughly 4 to 6 mg/kg/day orally [41].
Oxandrolone. This anabolic agent improves net protein balance and lean mass in severely burned patients, with associated upregulation of genes for functional muscle proteins [34]. In children, long-term oxandrolone produced significantly greater lean body mass at 6, 9, and 12 months and higher bone mineral content at 12 months [35], with the maximal effect in children aged 7 to 18 years [36]. The lean-mass gain has a clinical payoff: faster weight restoration with oxandrolone corresponded to a 30% decrease in length of stay in the burn rehabilitation unit [33].
Recombinant human growth hormone. Long-term low-dose growth hormone abates muscle catabolism and osteopenia and increases lean body mass at 6, 9, and 12 months [1], and growth hormone shortened length of stay per percent TBSA, translating to roughly a two-week reduction for an average large burn [37]. Its limitation is hyperglycemia and free-fatty-acid elevation, which is why it is often paired with propranolol: the combination attenuates hypermetabolism and inflammation without the adverse effects of growth hormone alone [38]. Combined oxandrolone and propranolol attenuates burn-induced growth arrest in pediatric patients [39].
Control glucose¶
Hyperglycemia is part of the stress response and is harmful. Persistent hyperglycemia was associated with markedly higher mortality (27% versus 4%) and worse skin-graft take than adequate glucose control [30]. Intensive insulin therapy in burned children improved insulin sensitivity and mitochondrial function while decreasing resting energy expenditure [31] and reduced infections and sepsis [32]. Insulin is not only a glycemic-control tool: exogenous insulin is anabolic, eliminating negative leg muscle protein balance by stimulating muscle protein synthesis roughly 350% in severely catabolic patients [55]. That anabolic effect comes from insulin and not from glucose load alone, because glucose infusion has a ceiling beyond which protein synthesis and glucose oxidation plateau while excess infusion drives carbon dioxide production and hepatic fat deposition [56]. The tradeoff is hypoglycemia, which intensive protocols increase, so glucose control is a balance rather than a race to the lowest number [49].
Micronutrients and glutamine¶
Burned children develop depleted micronutrient stores: low plasma zinc and copper inadequately compensated during hospitalization [46] and depressed selenium status below healthy norms [47]. Supplementation is common practice across burn centers, though dose, duration, and side effects remain uncertain [48]. Enteral glutamine supplementation improved wound healing and reduced hospital stay in burned patients (46.6 versus 55.7 days) while preserving the gut barrier [29].
Complications¶
The complications of pediatric burn metabolism arise from both the injury and its treatment. Untreated, the hypermetabolic response produces fatty liver with a twofold increase in liver size [7] and progressive lean-mass loss [9].
Glycemic complications dominate the treatment side. Post-burn hyperglycemia leads to graft failure and death [30]. Intensive insulin therapy decreased infections and sepsis [32], but increases hypoglycemia and carries its own risks [49]. Growth hormone's deleterious side effects include hyperglycemia [38].
Pharmacologic modulation is otherwise well tolerated in children. Propranolol did not increase the incidence of sepsis (7% versus 10% in controls) or infection (21% versus 30% in controls) and attenuates hypermetabolism without raising infection rates [54]. Propranolol reduces supraphysiologic thermogenesis, cardiac work, resting energy expenditure, and lipolysis [41], and combined oxandrolone and propranolol attenuates burn-induced growth arrest in pediatric patients [39].
Special Considerations¶
Age within the pediatric range matters. Children 0 to 3.9 years maintained lean body mass and body weight during acute hospitalization, whereas children over 4 years lost both [42], a pattern that complicates the assumption that the youngest are always most fragile metabolically. Infants under one year with burns over 30% TBSA do, however, have poorer survival than older children with similar injuries [43], and the small reserves of any growing child mean that hypermetabolism, which can demand up to two and a half times normal caloric intake, easily produces negative balance without careful management [53].
The persistence of the response shapes long-term care. Children suffer growth retardation after severe burns [44], and the hypermetabolic state delays anabolism and growth [15], which is the rationale for continuing anabolic and beta-blocking agents into the rehabilitation phase rather than stopping at discharge.
Controversies and Evidence Gaps¶
The mortality benefit of beta-blockade is not established. While propranolol's effect on hypermetabolism, energy expenditure, and lean mass is consistent across pediatric trials, a systematic review and meta-analysis found insufficient evidence to support or refute a beta-blocker advantage in children or adults after burns [50]. Practice reflects this uncertainty: there is wide variation in who receives propranolol, when, and at what dose, underscoring the need for consensus on duration and dosing [52].
The high-protein convention is also under challenge. Current guidelines advise high protein intake to counter catabolism, but a systematic review concluded there is only very weak evidence to justify high-protein diets after burns [51]. This sits in tension with the demonstrated protein-sparing benefit of carbohydrate-predominant feeding [20] and argues for measured rather than maximal protein delivery.
Glycemic targets remain unsettled in children specifically. Intensive glucose control may benefit burn patients, but the hypoglycemia it causes must be weighed, and the optimal target and protocol for children are not defined [49]. Finally, micronutrient supplementation, though widespread, lacks defined dosing and duration, with persistent uncertainty about benefit and side effects [48]. The throughline across these gaps is that the physiology of the pediatric hypermetabolic response is far better characterized than the comparative effectiveness of the interventions used to treat it.
References¶
[1] Hart DW et al. "Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy." Annals of surgery 2001. PMID: 11371741 ↩
[2] Branski LK et al. "Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children." Annals of surgery 2009. PMID: 19734776 ↩
[3] Herndon DN et al. "Long-term propranolol use in severely burned pediatric patients: a randomized controlled study." Annals of surgery 2012. PMID: 22895351 ↩
[4] Herndon DN et al. "Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients." Annals of surgery 1988. PMID: 3052328 ↩
[5] Herndon DN et al. "Reversal of catabolism by beta-blockade after severe burns." The New England journal of medicine 2001. PMID: 11680441 ↩
[6] Herndon DN et al. "Lipolysis in burned patients is stimulated by the beta 2-receptor for catecholamines." Archives of surgery (Chicago, Ill. : 1960) 1994. PMID: 7986160 ↩
[7] Aarsland A et al. "Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged." Annals of surgery 1996. PMID: 8645051 ↩
[8] Jahoor F et al. "Dynamics of the protein metabolic response to burn injury." Metabolism: clinical and experimental 1988. PMID: 3282147 ↩
[9] Hart DW et al. "Energy expenditure and caloric balance after burn: increased feeding leads to fat rather than lean mass accretion." Annals of surgery 2002. PMID: 11753055 ↩
[10] Caldwell FT et al. "The effect of occlusive dressings on the energy metabolism of severely burned children." Annals of surgery 1981. PMID: 7235763 ↩
[11] Jeschke MG et al. "Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences." Annals of surgery 2005. PMID: 15849511 ↩
[12] Cree MG et al. "Insulin resistance, secretion and breakdown are increased 9 months following severe burn injury." Burns : journal of the International Society for Burn Injuries 2009. PMID: 18672331 ↩
[13] Tuvdendorj D et al. "Skeletal muscle is anabolically unresponsive to an amino acid infusion in pediatric burn patients 6 months postinjury." Annals of surgery 2011. PMID: 21263308 ↩
[14] Diaz EC et al. "Predictors of muscle protein synthesis after severe pediatric burns." The journal of trauma and acute care surgery 2015. PMID: 25807408 ↩
[15] Prelack K et al. "Measures of Total Energy Expenditure and Its Components Using the Doubly Labeled Water Method in Rehabilitating Burn Children." JPEN. Journal of parenteral and enteral nutrition 2017. PMID: 26246223 ↩
[16] Dickerson RN et al. "Accuracy of predictive methods to estimate resting energy expenditure of thermally-injured patients." JPEN. Journal of parenteral and enteral nutrition 2002. PMID: 11833748 ↩
[17] Gore DC et al. "Comparison of resting energy expenditures and caloric intake in children with severe burns." The Journal of burn care & rehabilitation 1990. PMID: 2246309 ↩
[18] Suman OE et al. "Resting energy expenditure in severely burned children: analysis of agreement between indirect calorimetry and prediction equations using the Bland-Altman method." Burns : journal of the International Society for Burn Injuries 2006. PMID: 16529869 ↩
[19] Hildreth MA et al. "Current treatment reduces calories required to maintain weight in pediatric patients with burns." The Journal of burn care & rehabilitation 1990. PMID: 2123202 ↩
[20] Hart DW et al. "Efficacy of a high-carbohydrate diet in catabolic illness." Critical care medicine 2001. PMID: 11445678 ↩
[21] Peng YZ et al. "Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients." Burns : journal of the International Society for Burn Injuries 2001. PMID: 11226652 ↩
[22] Lam NN et al. "Early enteral feeding for burned patients--an effective method which should be encouraged in developing countries." Burns : journal of the International Society for Burn Injuries 2008. PMID: 17804169 ↩
[23] Shahi N et al. "Why Delay? Early Enteral Nutrition in Pediatric Burn Patients Improves Outcomes." Journal of burn care & research : official publication of the American Burn Association 2021. PMID: 32810219 ↩
[24] Wang S et al. "[Clinical study of the effect of early enteral feeding on reducing hypermetabolism after server burns]." Zhonghua wai ke za zhi [Chinese journal of surgery] 1997. PMID: 10374509 ↩
[25] Hudson AS et al. "Safety and Benefits of Intraoperative Enteral Nutrition in Critically Ill Pediatric Burn Patients: A Systematic Review and Pooled Analysis." Journal of burn care & research : official publication of the American Burn Association 2022. PMID: 35304893 ↩
[26] Pham CH et al. "How long are burn patients really NPO in the perioperative period and can we effectively correct the caloric deficit using an enteral feeding 'Catch-up' protocol?" Burns : journal of the International Society for Burn Injuries 2018. PMID: 30115532 ↩
[27] Czapran A et al. "International observational study of nutritional support in mechanically ventilated patients following burn injury." Burns : journal of the International Society for Burn Injuries 2015. PMID: 25445003 ↩
[28] Garrel DR et al. "Improved clinical status and length of care with low-fat nutrition support in burn patients." JPEN. Journal of parenteral and enteral nutrition 1995. PMID: 8748363 ↩
[29] Peng X et al. "Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients." Burns : journal of the International Society for Burn Injuries 2004. PMID: 15019120 ↩
[30] Gore DC et al. "Association of hyperglycemia with increased mortality after severe burn injury." The Journal of trauma 2001. PMID: 11535907 ↩
[31] Fram RY et al. "Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children." Critical care medicine 2010. PMID: 20400899 ↩
[32] Jeschke MG et al. "Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial." American journal of respiratory and critical care medicine 2010. PMID: 20395554 ↩
[33] Demling RH et al. "The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent." Burns : journal of the International Society for Burn Injuries 2001. PMID: 11164665 ↩
[34] Wolf SE et al. "Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned." Annals of surgery 2003. PMID: 12796576 ↩
[35] Murphy KD et al. "Effects of long-term oxandrolone administration in severely burned children." Surgery 2004. PMID: 15300183 ↩
[36] Porro LJ et al. "Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy." Journal of the American College of Surgeons 2012. PMID: 22463890 ↩
[37] Herndon DN et al. "Effects of recombinant human growth hormone on donor-site healing in severely burned children." Annals of surgery 1990. PMID: 2121109 ↩
[38] Jeschke MG et al. "Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children." Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2008. PMID: 18477935 ↩
[39] Herndon DN et al. "Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children." Annals of surgery 2016. PMID: 27433905 ↩
[40] Barrow RE et al. "The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly." Annals of surgery 2006. PMID: 16371745 ↩
[41] Núñez-Villaveirán T et al. "Systematic review of the effect of propanolol on hypermetabolism in burn injuries." Medicina intensiva 2015. PMID: 25305241 ↩
[42] Jeschke MG et al. "Age differences in inflammatory and hypermetabolic postburn responses." Pediatrics 2008. PMID: 18310198 ↩
[43] Sheridan R et al. "Treatment of the seriously burned infant." The Journal of burn care & rehabilitation 1998. PMID: 9556311 ↩
[44] Wang F et al. "[Advancement in the research of growth hormone in treating pediatric burn patients]." Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 2013. PMID: 23710719 ↩
[45] Rivas E et al. "Short-term metformin and exercise training effects on strength, aerobic capacity, glycemic control, and mitochondrial function in children with burn injury." American journal of physiology. Endocrinology and metabolism 2018. PMID: 29138224 ↩
[46] Voruganti VS et al. "Impaired zinc and copper status in children with burn injuries: need to reassess nutritional requirements." Burns : journal of the International Society for Burn Injuries 2005. PMID: 16006043 ↩
[47] Dylewski ML et al. "The selenium status of pediatric patients with burn injuries." The Journal of trauma 2010. PMID: 20838129 ↩
[48] Caldis-Coutris N et al. "Zinc supplementation in burn patients." Journal of burn care & research : official publication of the American Burn Association 2012. PMID: 22245802 ↩
[49] Won P et al. "Blood glucose control in the burn intensive care unit: A narrative review of literature." Burns : journal of the International Society for Burn Injuries 2023. PMID: 37385891 ↩
[50] Hassoun-Kheir N et al. "The Effect of β-Blockers for Burn Patients on Clinical Outcomes: Systematic Review and Meta-Analysis." Journal of intensive care medicine 2021. PMID: 32686565 ↩
[51] Hampton V et al. "Evaluation of high protein intake to improve clinical outcome and nutritional status for patients with burns: a systematic review." Burns : journal of the International Society for Burn Injuries 2021. PMID: 33722450 ↩
[52] LeCompte MT et al. "A survey of the use of propranolol in burn centers: Who, what, when, why." Burns : journal of the International Society for Burn Injuries 2017. PMID: 27575676 ↩
[53] Solomon JR "Nutrition in the severely burned child." Progress in pediatric surgery 1981. PMID: 6784187 ↩
[54] Jeschke MG et al. "Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children." The Journal of trauma 2007. PMID: 17414346 ↩
[55] Sakurai Y et al. "Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients." Annals of surgery 1995. PMID: 7677459 ↩
[56] Burke JF et al. "Glucose requirements following burn injury. Parameters of optimal glucose infusion and possible hepatic and respiratory abnormalities following excessive glucose intake." Annals of surgery 1979. PMID: 485602 ↩
[57] Hildreth MA et al. "Reassessing caloric requirements in pediatric burn patients." The Journal of burn care & rehabilitation 1988. PMID: 3146576 ↩
Educational reference — not medical advice. Disclaimer